Arcelor Mittal Q3 Profit Down On Weak Production

Steel and mining major Arcelor Mittal SA (MT) reported Thursday that its third-quarter net income attributable to equity holders of the parent declined to $993 million from last year's $4.62 million.

Basic earnings per share were $1.11, down from $4.17 a year ago.

Sales declined to $18.98 billion from last year's $20.23 billion.

Crude steel production fell to 14.9 million tonnes from prior year's 17.2 million tonnes. Steel shipments also declined to 13.6 million tonnes from 14.6 million tonnes a year ago.

Looking ahead, the company said the short-term outlook for the industry remains uncertain and caution is appropriate.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
IBSA Pharma Inc. is recalling 27 lots of TIROSINT-SOL (levothyroxine sodium) Oral Solution to the consumer level due to subpotency, the U.S. Food and Drug Administration said. TIROSINT-SOL is indicated for Hypothyroidism and Pituitary Thyrotropin (Thyroid-Stimulating Hormone, TSH) Suppression. Meanwhile, the recall does not apply to TIROSINT (levothyroxine sodium) capsules. The U.S. Food and Drug Administration approved GlaxoSmithKline LLC's Jesduvroq tablets (daprodustat) for anemia caused by chronic kidney disease or CKD for adults who have been receiving dialysis for at least four months. It is the first oral treatment for anemia, i.e., decreased number of red blood cells, in the given indication that has received FDA approval. German banking major Deutsche Bank AG reported Thursday a significantly higher profit in its fourth quarter and fiscal 2022, mainly reflecting a tax benefit in the U.S, despite weakness in Investment Bank and asset management revenues. The company said it recorded its highest annual profit, both before and after tax, since 2007. However, Deutsche Bank shares were losing around 4 percent...
Follow RTT